University of Pennsylvania
A Research Specialist at the Perelman School of Medicine will support publication-driven translational immunology projects focused on immune dysregulation and identifying biomarkers for type 1 diabetes. The role combines laboratory work (sample processing, cell culture, flow cytometry, and sequencing library preparation) with computational analysis of bulk and single-cell sequencing datasets. The position offers independence, opportunities for project leadership, and collaboration within a multidisciplinary research team.
Headquarters
Philadelphia, Pennsylvania, United States
Company Size
10001+ employees
Founded
1740
The University of Pennsylvania (Penn) is a private Ivy League research university in Philadelphia offering undergraduate, graduate, and professional programs across schools such as Wharton (business), Penn Medicine, SEAS (engineering), Law, Nursing, and the School of Arts & Sciences. Penn emphasizes interdisciplinary research, innovation, and entrepreneurship, translating scholarship into clinical care, startups, and public policy. Founded in the 18th century with ties to Benjamin Franklin, it maintains a large research enterprise, global partnerships, and a broad alumni network.
DeFi leaders push for more decentralized finance in US university curricula
1 day ago
2025 Best Undergraduate Business Professors: Tiantian Yang, The Wharton School at University of Pennsylvania
Dec 1, 2025
University of Pennsylvania launches $50m fund with pharma group BioNTech
Jan 12, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for University of Pennsylvania.
University of Pennsylvania launches $10M startup fund
Dec 15, 2025
Senior Scientist I / II – Translational Immuno‑Oncology Research (OTR)
Novartis
Senior Scientist I / II – Translational Immuno‑Oncology Research (OTR)
Novartis
Senior Scientist, Computational Biology
allogene
Senior Scientist/ Scientist II, Systems Immunologist
immunai
Translational Scientist (Senior)
Bioptimus
Post Doc – Meyer Lab
University of Colorado